Blue Trust Inc
ASND icon

Blue Trust Inc’s Ascendis Pharma A/S ASND Stock Holding History

Blue Trust Inc’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-170
Closed -$45.3K – 2539
2026
Q2 		$45.3K Hold
170
– – ﹤0.01% 1382
2026
Q1 		$38.9K Sell
170
-157
-48% -$35.2K ﹤0.01% 1430
2025
Q4 		$69.7K Hold
327
– – ﹤0.01% 1224
2025
Q3 		$65K Hold
327
– – ﹤0.01% 1276
2025
Q2 		$56.4K Sell
327
-41
-11% -$6.68K ﹤0.01% 1386
2025
Q1 		$57.4K Sell
368
-39
-10% -$5.57K ﹤0.01% 1272
2024
Q4 		$56K Buy
407
+328
+415% +$43.1K ﹤0.01% 1251
2024
Q3 		$10.8K Buy
79
+13
+20% +$1.76K ﹤0.01% 2172
2024
Q2 		$10K Buy
+66
New +$8.98K ﹤0.01% 1928
2023
Q1 		– Sell
-6
Closed -$1K – 2294
2022
Q4 		$1K Sell
6
-1
-14% -$116 ﹤0.01% 2007
2022
Q3 		$1K Buy
+7
New +$664 ﹤0.01% 1878

Other funds holding ASND

Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Henry James International Management
Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Blue Trust Inc's ASND Position: Q3 2026 in Review

Blue Trust Inc sold out of Ascendis Pharma A/S (ASND) in Q3 2026, closing a stake of 170 shares — an estimated $45.3K sold.

Blue Trust Inc first reported a position in ASND in Q3 2022 and held it in 11 quarters. The position peaked at $69.7K in Q4 2025. 63 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Blue Trust Inc reported no remaining Ascendis Pharma A/S position as of Q3 2026 after selling out during the quarter.
  • Blue Trust Inc sold 170 Ascendis Pharma A/S shares in Q3 2026, an estimated $45.3K.
  • Blue Trust Inc first reported a position in Ascendis Pharma A/S in Q3 2022 and held it in 11 quarters.
  • Blue Trust Inc's Ascendis Pharma A/S position peaked at $69.7K in Q4 2025.
  • 63 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.